Autosomal recessive spastic paraplegia-92 (SPG92) is a slowly progressive neurodegenerative disorder with onset of lower limb spasticity and gait abnormalities in the first (more common) or second decade of life. More variable features include upper limb involvement, tremor, urinary urgency, muscle weakness and atrophy, and mild peripheral neuropathy. Mild cognitive deficits have been reported in some patients (Rebelo et al., 2022).
For a general phenotypic description and a discussion of genetic heterogeneity of autosomal recessive spastic paraplegia, see 270800. [from OMIM]
Also known as: HIP13, HYPE, SPG92, UNQ3041, FICD
Summary: FIC domain protein adenylyltransferase
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.